Long-term treatment with Duvyzat (givinostat) may help delay the loss of walking ability and lessen the decline in lung ...
13hon MSN
Every so often, Wall Street sends a not-so-subtle reminder to investors that stocks can move in both directions. Between the ...
Born with Duchenne muscular dystrophy and diagnosed at 4 months old in 1996, he is currently based in the Eastern part of Singapore. His hope for his column is to advocate for the health and ...
Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death of a patient taking Sarepta’s Elevidys raises important safety questions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback